Butantan dengue vaccine achieves 79.6% effectiveness
The dengue vaccine developed by the Butantan Institute was 79.6% effective in clinical trials. According to the institution, follow-up with ...
The dengue vaccine developed by the Butantan Institute was 79.6% effective in clinical trials. According to the institution, follow-up with ...
For the fourth consecutive year, this Wednesday (14th), Empresa Brasil de Comunicação (EBC) was recognized with level 1 in the ...
Folha Nobre - Desde 2013 - ©